Basic helix-loop-helix transcription factor NEUROG1 and schizophrenia: Effects on illness susceptibility, MRI brain morphometry and cognitive abilities

Schizophrenia Research

Volumn 106, Issue 2-3, 2008, Pages 192-199

  Ho, Beng Choon ^a   Epping, Eric ^a   Wang, Kai ^b   Andreasen, Nancy C ^a   Librant, Amy ^a   Wassink, Thomas H ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Candidate gene; Cognition; Endophenotype; MRI; Neurogenin; Schizophrenia

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CYTOSINE; GUANINE; NEUROGENIN 1;

ADULT; ALLELE; ARTICLE; BRAIN SIZE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; GRAY MATTER; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 56049090770     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.08.009     Document Type: Article

References (70)

1. Almasy, L., Gur, R.C., Haack, K., Cole, S.A., Calkins, M.E., Peralta, J.M., Hare, E., Prasad, K., Pogue-Geile, M.F., Nimgaonkar, V., Gur, R.E., in press. A genome screen for quantitative trait loci influencing schizophrenia and neuro-cognitive phenotypes. Am. J. Psychiatry. (Electronic publication ahead of print). doi:10.1176/appi.ajp.2008.07121869.
2. Andreasen N.C., Flaum M., and Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 49 (1992) 615-623
3. Andreasen N.C., Cizadlo T., Harris G., Swayze V., O'Leary D.S., Cohen G., Ehrhardt J., and Yuh W.T. Voxel processing techniques for the antemortem study of neuroanatomy and neuropathology using magnetic resonance imaging. J. Neuropsychiatry. Clin. Neurosci. 5 (1993) 121-130
4. Andreasen N.C., Flashman L., Flaum M., Arndt S., Swayze II V., O'Leary D.S., Ehrhardt J.C., and Yuh W.T. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 272 (1994) 1763-1769
5. Andreasen N.C., Rajarethinam R., Cizadlo T., Arndt S., Swayze II V.W., Flashman L.A., O'Leary D.S., Ehrhardt J.C., and Yuh W.T. Automatic atlas-based volume estimation of human brain regions from MR images. J. Comput. Assist. Tomogr. 20 (1996) 98-106
6. Bertrand N., Castro D.S., and Guillemot F. Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 3 (2002) 517-530
7. Blader P., Plessy C., and Strahle U. Multiple regulatory elements with spatially and temporally distinct activities control neurogenin1 expression in primary neurons of the zebrafish embryo. Mech. Dev. 120 (2003) 211-218
8. Blanchard J.J., and Neale J.M. The neuropsychological signature of schizophrenia: generalized or differential deficit?. Am. J. Psychiatry 151 (1994) 40-48
9. Botstein D., and Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 33 (2003) 228-237 Suppl
10. Brzustowicz L.M., Simone J., Mohseni P., Hayter J.E., Hodgkinson K.A., Chow E.W., and Bassett A.S. Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am. J. Hum. Genet. 74 (2004) 1057-1063
11. Cau E., Gradwohl G., Fode C., and Guillemot F. Mash1 activates a cascade of bHLH regulators in olfactory neuron progenitors. Development 124 (1997) 1611-1621
12. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.P., Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.M., Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.J., Bouillot M., Sambucy J.L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M., Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D., Gimalac A., Van Duijn C., Gauvreau D., Ouellette G., Fortier I., Raelson J., Sherbatich T., Riazanskaia N., Rogaev E., Raeymaekers P., Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E., Weinberger D.R., Cohen N., and Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13675-13680
13. Craddock N., O'Donovan M.C., and Owen M.J. Phenotypic and genetic complexity of psychosis. Invited commentary on ... Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 190 (2007) 200-203
14. Fanous A.H., Chen X., Wang X., Amdur R.L., O'Neill F.A., Walsh D., and Kendler K.S. Association between the 5q31.1 gene neurogenin1 and schizophrenia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144 (2007) 207-214
15. Fode C., Ma Q., Casarosa S., Ang S.L., Anderson D.J., and Guillemot F. A role for neural determination genes in specifying the dorsoventral identity of telencephalic neurons. Genes. Dev. 14 (2000) 67-80
16. Georgieva L., Moskvina V., Peirce T., Norton N., Bray N.J., Jones L., Holmans P., Macgregor S., Zammit S., Wilkinson J., Williams H., Nikolov I., Williams N., Ivanov D., Davis K.L., Haroutunian V., Buxbaum J.D., Craddock N., Kirov G., Owen M.J., and O'Donovan M.C. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12469-12474
17. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 158 (2001) 1367-1377
18. Goldstein D.B., Cavalleri G.L., and Ahmadi K.R. The genetics of common diseases: 10 million times as hard. Cold Spring Harb Symp. Quant. Biol. 68 (2003) 395-401
19. Gowan K., Helms A.W., Hunsaker T.L., Collisson T., Ebert P.J., Odom R., and Johnson J.E. Crossinhibitory activities of Ngn1 and Math1 allow specification of distinct dorsal interneurons. Neuron 31 (2001) 219-232
20. Gradwohl G., Fode C., and Guillemot F. Restricted expression of a novel murine atonal-related bHLH protein in undifferentiated neural precursors. Dev. Biol. 180 (1996) 227-241
21. Green M.F., Nuechterlein K.H., Gold J.M., Barch D.M., Cohen J., Essock S., Fenton W.S., Frese F., Goldberg T.E., Heaton R.K., Keefe R.S., Kern R.S., Kraemer H., Stover E., Weinberger D.R., Zalcman S., and Marder S.R. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol. Psychiatry 56 (2004) 301-307
22. Harris G., Andreasen N.C., Cizadlo T., Bailey J.M., Bockholt H.J., Magnotta V.A., and Arndt S. Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. J. Comput. Assist. Tomogr. 23 (1999) 144-154
23. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12 (1998) 426-445
24. Helms A.W., Abney A.L., Ben-Arie N., Zoghbi H.Y., and Johnson J.E. Autoregulation and multiple enhancers control Math1 expression in the developing nervous system. Development 127 (2000) 1185-1196
25. Hermann A., Maisel M., Liebau S., Gerlach M., Kleger A., Schwarz J., Kim K.S., Antoniadis G., Lerche H., and Storch A. Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells. J. Neurochem. 98 (2006) 629-640
26. Hill S.K., Schuepbach D., Herbener E.S., Keshavan M.S., and Sweeney J.A. Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naive patients with schizophrenia. Schizophr. Res. 68 (2004) 49-63
27. Ho B.C., Alicata D., Ward J., Moser D.J., O'Leary D.S., Arndt S., and Andreasen N.C. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am. J. Psychiatry 160 (2003) 142-148
28. Honea R., Crow T.J., Passingham D., and Mackay C.E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry 162 (2005) 2233-2245
29. Kamnasaran D., Muir W.J., Ferguson-Smith M.A., and Cox D.W. Disruption of the neuronal PAS3 gene in a family affected with schizophrenia. J. Med. Genet. 40 (2003) 325-332
30. Kareken D.A., Gur R.C., Mozley D., Mozley L.H., Saykin A.J., Shtasel D.L., and Gur R.E. Cognitive functioning and neuroanatomic volume measures in schizophrenia. Neuropsychology 9 (1995) 211-219
31. Kendler K.S., Myers J.M., O'Neill F.A., Martin R., Murphy B., MacLean C.J., Walsh D., and Straub R.E. Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. Am. J. Psychiatry 157 (2000) 402-408
32. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19 (1991) 5444
33. Latchman D.S. Transcription-factor mutations and disease. N. Engl. J. Med. 334 (1996) 28-33
34. Lewis D.A., and Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33 (2008) 141-165
35. Ma Q., Sommer L., Cserjesi P., and Anderson D.J. Mash1 and neurogenin1 expression patterns define complementary domains of neuroepithelium in the developing CNS and are correlated with regions expressing notch ligands. J. Neurosci. 17 (1997) 3644-3652
36. McClellan J.M., Susser E., and King M.C. Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 190 (2007) 194-199
37. McCormick M.B., Tamimi R.M., Snider L., Asakura A., Bergstrom D., and Tapscott S.J. NeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family. Mol. Cell Biol. 16 (1996) 5792-5800
38. Milev P., Ho B.C., Arndt S., and Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatry 162 (2005) 495-506
39. Mitchell P.J., and Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245 (1989) 371-378
40. Mohamed S., Paulsen J., O'Leary D., Arndt S., and Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch. Gen. Psychiatry 56 (1999) 749-754
41. Murray R.C., Tapscott S.J., Petersen J.W., Calof A.L., and McCormick M.B. A fragment of the Neurogenin1 gene confers regulated expression of a reporter gene in vitro and in vivo. Dev. Dyn. 218 (2000) 189-194
42. Murray R.M., and Lewis S.W. Is schizophrenia a neurodevelopmental disorder?. Br. Med. J. Clin. Res. Ed. 295 (1987) 681-682
43. Nakada Y., Parab P., Simmons A., Omer-Abdalla A., and Johnson J.E. Separable enhancer sequences regulate the expression of the neural bHLH transcription factor neurogenin 1. Dev. Biol. 271 (2004) 479-487
44. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52 (1995) 998-1007
45. Owen M.J., Williams N.M., and O'Donovan M.C. The molecular genetics of schizophrenia: new findings promise new insights. Mol. Psychiatry 9 (2004) 14-27
46. Pickard B.S., Malloy M.P., Porteous D.J., Blackwood D.H., and Muir W.J. Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 136 (2005) 26-32
47. Pieper A.A., Wu X., Han T.W., Estill S.J., Dang Q., Wu L.C., Reece-Fincanon S., Dudley C.A., Richardson J.A., Brat D.J., and McKnight S.L. The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14052-14057
48. Saykin A.J., Shtasel D.L., Gur R.E., Kester D.B., Mozley L.H., Stafiniak P., and Gur R.C. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psychiatry 51 (1994) 124-131
49. Schuurmans C., Armant O., Nieto M., Stenman J.M., Britz O., Klenin N., Brown C., Langevin L.M., Seibt J., Tang H., Cunningham J.M., Dyck R., Walsh C., Campbell K., Polleux F., and Guillemot F. Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways. Embo. J. 23 (2004) 2892-2902
50. Schwab S.G., Eckstein G.N., Hallmayer J., Lerer B., Albus M., Borrmann M., Lichtermann D., Ertl M.A., Maier W., and Wildenauer D.B. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol. Psychiatry 2 (1997) 156-160
51. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., Lerer B., Rietschel M., Trixler M., Maier W., and Wildenauer D.B. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 72 (2003) 185-190
52. Shenton M.E., Dickey C.C., Frumin M., and McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 49 (2001) 1-52
53. Simmons A.D., Horton S., Abney A.L., and Johnson J.E. Neurogenin2 expression in ventral and dorsal spinal neural tube progenitor cells is regulated by distinct enhancers. Dev. Biol. 229 (2001) 327-339
54. Skol A.D., Young K.A., Tsuang D.W., Faraone S.V., Haverstock S.L., Bingham S., Prabhudesai S., Mena F., Menon A.S., Yu C.E., Rundell P., Pepple J., Sauter F., Baldwin C., Weiss D., Collins J., Keith T., Boehnke M., Schellenberg G.D., and Tsuang M.T. Modest evidence for linkage and possible confirmation of association between NOTCH4 and schizophrenia in a large Veterans Affairs Cooperative Study sample. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 118 (2003) 8-15
55. Sommer L., Ma Q., and Anderson D.J. Neurogenins, a novel family of atonal-related bHLH transcription factors, are putative mammalian neuronal determination genes that reveal progenitor cell heterogeneity in the developing CNS and PNS. Mol. Cell Neurosci. 8 (1996) 221-241
56. Steen R.G., Mull C., McClure R., Hamer R.M., and Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 188 (2006) 510-518
57. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., and Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71 (2002) 877-892
58. Sullivan P.F., Kendler K.S., and Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60 (2003) 1187-1192
59. Sun Y., Nadal-Vicens M., Misono S., Lin M.Z., Zubiaga A., Hua X., Fan G., and Greenberg M.E. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 104 (2001) 365-376
60. Takao T., Tachikawa H., Kawanishi Y., Mizukami K., and Asada T. CLOCK gene T3111C polymorphism is associated with Japanese schizophrenics: a preliminary study. Eur. Neuropsychopharmacol. 17 (2007) 273-276
61. Talairach J., and Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain (1988), Thieme Medical Publishers, New York
62. Taylor M.A., and Abrams R. Cognitive impairment in schizophrenia. Am. J. Psychiatry 141 (1984) 196-201
63. Verma-Kurvari S., Savage T., Smith D., and Johnson J.E. Multiple elements regulate Mash1 expression in the developing CNS. Dev. Biol. 197 (1998) 106-116
64. Vita A., De Peri L., Silenzi C., and Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr. Res. 82 (2006) 75-88
65. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., and Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320 (2008) 539-543
66. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44 (1987) 660-669
67. Woods R.P., Cherry S.R., and Mazziotta J.C. Rapid automated algorithm for aligning and reslicing PET images. J. Comput. Assist. Tomogr. 16 (1992) 620-633
68. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., and Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 157 (2000) 16-25
69. Xu B., Roos J.L., Levy S., van Rensburg E.J., Gogos J.A., and Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 40 (2008) 880-885
70. Zaharieva I., Georgieva L., Nikolov I., Kirov G., Owen M.J., O'Donovan M.C., and Toncheva D. Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping. BMC Psychiatry 8 (2008) 11